Phase 4 Sickle Cell Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with sickle cell anemia (HbSS) or a related condition called sickle-β0-thalassemia (HbSβ0).
- People who are at least 6 months old at the time of joining the trial.
- People whose patient, family, and doctor have together decided to start treatment with a medication called hydroxyurea.
Who may not be able to join:
- People who are currently receiving regular scheduled blood transfusions.
- People who have a related but different condition called sickle-hemoglobin C disease (HbSC) or sickle-β+-thalassemia (HbSβ+).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Charles T. Quinn, Professor of Pediatrics, M.D., M.S., Children's Hospital Medical Center, Cincinnati
Phone: 513-803-3064
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Composite Organ Injury
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.